Rapid Micro Biosystems (RPID) - Net/Net Netting Bugs out of our Medicines

Today, White Brook Capital published its company evaluation of Rapid Micro Biosystems, ticker RPID, an automated quality control company for pharmaceutical manufacturers.

We believe it’s worth your time.

https://www.whitebrookcapital.com/investment-theses/rapidmicrobio

All investments involve risk, including loss of principal. This document provides information not intended to meet objectives or suitability requirements of any specific individual. This information is provided for educational or discussion purposes only and should not be considered investment advice or a solicitation to buy or sell securities. The information contained herein has been drawn from sources which we believe to be reliable; however, its accuracy or completeness is not guaranteed. This report is not to be construed as an offer, solicitation or recommendation to buy or sell any of the securities herein named. We may or may not continue to hold any of the securities mentioned. White Brook Capital LLC and/or their respective officers, directors, partners or employees may from time to time acquire, hold or sell securities named in this report. It should not be assumed that any of the securities transactions or holdings discussed were or will prove to be profitable, or that the investment decisions we make in the future will be profitable or will equal the investment performance of the securities discussed herein